OncoImmune competitorsClear all

Taiho Pharmaceutical's top competitors include InnoCare, Spectrum Pharmaceuticals and Halozyme Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Taiho Pharmaceutical
Taiho Pharmaceutical
Taiho Pharmaceutical (大鵬薬品) is a company focused on oncology, allergy, immunology, and urology fields.
InnoCare
InnoCare
InnoCare is a biopharmaceutical company specializing in drug development for the treatment of cancer and autoimmune diseases.
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Founding Date
Founding Date
1963
Founding Date
2013
Founding Date
2002
Founding Date
1998
Type
Type
Subsidiary
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Chiyoda City, JP HQ
Oakville, CA
Singapore, SG
Menlo Park, US
Princeton, US
Locations
CN HQ
Nanjing Shi, CN
Cambridge, US
Princeton, US
Locations
Henderson, US HQ
Irvine, US
Locations
San Diego, US HQ
Employees
Employees
117
Employees
734% increase
Employees
14638% decrease
Employees
1363% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
336.1 m
Valuation ($)
5.4 b
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
295769
Alexa Website Rank
419291
Alexa Website Rank
242121
Employee Rating
Employee Rating
N/A
Employee Rating
4
Employee Rating
2.9
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$267.6m (FY, 2020)
Net income
Net income
N/A
Net income
N/A
Net income
($160.9m) (FY, 2020)
Net income
$129.1m (FY, 2020)

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
3 (FY, 2016)
Phase I Trials Products
10 (FY, 2020)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
1 (FY, 2016)
Phase II Trials Products
1 (FY, 2020)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
3 (FY, 2016)
Phase III Trials Products
8 (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 215m
Total funding raised
$ 3m
Total funding raised
$ 45m
For sources of this data, please see the company profile

View company profiles

InnoCare
HQ
CN
Employees
73↑ 4% increase

InnoCare is a biopharmaceutical company specializing in drug development for the treatment of cancer and autoimmune diseases.

View company
Spectrum Pharmaceuticals
HQ
Henderson, US
Employees
146↓ 38% decrease

Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology.

View company
Halozyme Therapeutics
HQ
San Diego, US
Employees
136↑ 3% increase

Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company